Avidity Biosciences Inc. (RNA) NASDAQ
$29.51 0.60 (2.08%)
Market Cap: $2.82B
As of 05/15/24 04:00 PM EDT. Market closed.
Avidity Biosciences Inc. (RNA)
NASDAQ
$29.51
0.60 (2.08%)
Market Cap: $2.82B
As of 05/15/24 04:00 PM EDT. Market closed.
avidity biosciences is pioneering a new class of precision medicines – antibody-sirna conjugates (asc™) – to deliver nucleic acid therapeutics against genetic drivers of disease. our ascs have drug-like properties similar to antibodies and antibody-drug conjugates. importantly, their unique sirna-based “payloads” permit selective targeting of disease-associated mrnas against virtually ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Boyce Sarah | President and CEO | May 07, 2024 | Option Exercise | $1.24 | 28,000 | 34,720 | 140,117 | May 07, 2024, 09:52 PM |
Boyce Sarah | President and CEO | May 07, 2024 | Sale | $25.54 | 28,000 | 715,050 | 112,117 | May 07, 2024, 09:52 PM |
LEVIN ARTHUR A | Director | Apr 19, 2024 | Option Exercise | $1.24 | 5,000 | 6,200 | 19,830 | Apr 22, 2024, 05:28 PM |
LEVIN ARTHUR A | Director | Apr 19, 2024 | Sale | $22.82 | 5,000 | 114,123 | 14,830 | Apr 22, 2024, 05:28 PM |
LEVIN ARTHUR A | Director | Apr 03, 2024 | Sale | $27.11 | 20,000 | 542,214 | 253,872 | Apr 03, 2024, 08:26 PM |
Boyce Sarah | President and CEO | Apr 02, 2024 | Option Exercise | $1.24 | 28,000 | 34,720 | 140,117 | Apr 03, 2024, 06:16 PM |
Boyce Sarah | President and CEO | Apr 02, 2024 | Sale | $26.25 | 28,000 | 734,919 | 112,117 | Apr 03, 2024, 06:16 PM |
LEVIN ARTHUR A | Director | Mar 19, 2024 | Option Exercise | $1.24 | 5,000 | 6,200 | 19,830 | Mar 21, 2024, 04:10 PM |
LEVIN ARTHUR A | Director | Mar 19, 2024 | Sale | $23.97 | 5,000 | 119,847 | 14,830 | Mar 21, 2024, 04:10 PM |
MacLean Michael F | Chief Financial Officer | Mar 13, 2024 | Option Exercise | $8.82 | 40,000 | 352,800 | 84,093 | Mar 15, 2024, 04:12 PM |
MacLean Michael F | Chief Financial Officer | Mar 13, 2024 | Sale | $24.52 | 40,000 | 980,760 | 44,093 | Mar 15, 2024, 04:12 PM |
LEVIN ARTHUR A | Director | Mar 12, 2024 | Option Exercise | $1.24 | 25,000 | 31,000 | 42,471 | Mar 12, 2024, 08:41 PM |
LEVIN ARTHUR A | Director | Mar 12, 2024 | Sale | $22.03 | 27,641 | 609,017 | 17,471 | Mar 12, 2024, 08:41 PM |
Boyce Sarah | President and CEO | Mar 12, 2024 | Option Exercise | $1.24 | 28,000 | 34,720 | 140,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 08, 2024 | Option Exercise | $1.24 | 84,000 | 104,160 | 196,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 08, 2024 | Sale | $21.39 | 84,000 | 1,796,710 | 112,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 12, 2024 | Sale | $22.63 | 28,000 | 633,682 | 112,117 | Mar 12, 2024, 05:29 PM |
Boyce Sarah | President and CEO | Mar 01, 2024 | Option Exercise | $1.24 | 84,000 | 104,160 | 196,117 | Mar 05, 2024, 04:53 PM |
Boyce Sarah | President and CEO | Mar 01, 2024 | Sale | $20.13 | 84,000 | 1,691,306 | 112,117 | Mar 05, 2024, 04:53 PM |
LEVIN ARTHUR A | Director | Jan 22, 2024 | Sale | $10.13 | 1,859 | 18,832 | 17,471 | Jan 23, 2024, 03:14 PM |
Boyce Sarah | President and CEO | Jan 22, 2024 | Sale | $10.13 | 5,092 | 51,582 | 44,008 | Jan 23, 2024, 03:13 PM |
Flanagan W. Michael | CSTO | Jan 22, 2024 | Sale | $10.13 | 4,129 | 41,827 | 35,871 | Jan 23, 2024, 03:12 PM |
McCarthy Teresa | Chief Human Resources Officer | Jan 22, 2024 | Sale | $10.13 | 2,065 | 20,918 | 17,035 | Jan 23, 2024, 03:11 PM |
MacLean Michael F | Chief Financial Officer | Jan 22, 2024 | Sale | $10.13 | 1,616 | 16,370 | 16,884 | Jan 23, 2024, 03:11 PM |
LEVIN ARTHUR A | Director | Mar 15, 2023 | Option Exercise | $1.24 | 100 | 124 | 19,430 | Mar 17, 2023, 04:36 PM |
LEVIN ARTHUR A | Director | Mar 15, 2023 | Sale | $22.01 | 100 | 2,201 | 19,330 | Mar 17, 2023, 04:36 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Feb 14, 2023 | Option Exercise | $1.24 | 10,000 | 12,400 | 29,330 | Feb 15, 2023, 08:30 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Feb 14, 2023 | Sale | $23.66 | 10,000 | 236,567 | 19,853 | Feb 15, 2023, 08:30 PM |
Boyce Sarah | President and CEO | Feb 01, 2023 | Option Exercise | $1.24 | 900 | 1,116 | 54,252 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 03, 2023 | Option Exercise | $1.24 | 3,221 | 3,994 | 56,573 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 02, 2023 | Option Exercise | $1.24 | 45,879 | 56,890 | 99,231 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 03, 2023 | Sale | $24.26 | 3,221 | 78,141 | 53,352 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 02, 2023 | Sale | $24.36 | 45,879 | 1,117,741 | 53,352 | Feb 03, 2023, 05:26 PM |
Boyce Sarah | President and CEO | Feb 01, 2023 | Sale | $24.27 | 900 | 21,844 | 53,352 | Feb 03, 2023, 05:26 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jan 12, 2023 | Option Exercise | $1.24 | 10,000 | 12,400 | 11,330 | Jan 17, 2023, 08:50 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jan 12, 2023 | Sale | $22.00 | 10,000 | 220,028 | 1,330 | Jan 17, 2023, 08:50 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Dec 29, 2022 | Option Exercise | $1.24 | 40,000 | 49,600 | 41,330 | Jan 03, 2023, 05:40 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Dec 29, 2022 | Sale | $22.01 | 40,000 | 880,568 | 1,330 | Jan 03, 2023, 05:40 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 15, 2022 | Option Exercise | $0.92 | 62,498 | 57,802 | 63,828 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 12, 2022 | Option Exercise | $0.53 | 14,003 | 7,422 | 15,333 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 16, 2022 | Option Exercise | $1.24 | 3,499 | 4,339 | 4,829 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 15, 2022 | Sale | $22.12 | 62,498 | 1,382,343 | 1,330 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 12, 2022 | Sale | $22.00 | 14,003 | 308,066 | 1,330 | Aug 31, 2022, 08:08 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Aug 16, 2022 | Sale | $22.08 | 3,499 | 77,257 | 1,330 | Aug 31, 2022, 08:08 PM |
Boyce Sarah | President and CEO | Aug 24, 2022 | Option Exercise | $1.24 | 35,045 | 43,456 | 35,045 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 25, 2022 | Option Exercise | $1.24 | 14,855 | 18,420 | 14,855 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 24, 2022 | Sale | $22.80 | 35,045 | 798,924 | 0 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 25, 2022 | Sale | $23.07 | 14,855 | 342,690 | 0 | Aug 26, 2022, 07:29 PM |
Boyce Sarah | President and CEO | Aug 15, 2022 | Option Exercise | $1.24 | 100 | 124 | 100 | Aug 17, 2022, 09:40 PM |
Boyce Sarah | President and CEO | Aug 15, 2022 | Sale | $22.47 | 100 | 2,247 | 0 | Aug 17, 2022, 09:40 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Nov 18, 2021 | Option Exercise | $1.22 | 25,000 | 30,571 | 26,330 | Nov 22, 2021, 08:22 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Nov 18, 2021 | Sale | $27.89 | 25,000 | 697,218 | 1,330 | Nov 22, 2021, 08:22 PM |
RTW INVESTMENTS, LP | 10% Owner | Aug 04, 2021 | Buy | $18.00 | 800,000 | 14,400,000 | 4,795,000 | Aug 06, 2021, 11:20 AM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 25, 2021 | Option Exercise | $1.13 | 20,100 | 22,735 | 21,430 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 24, 2021 | Option Exercise | $1.24 | 100 | 124 | 1,430 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 25, 2021 | Sale | $28.12 | 20,100 | 565,299 | 3,977 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 24, 2021 | Sale | $27.75 | 100 | 2,775 | 1,330 | Jun 28, 2021, 07:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 17, 2021 | Option Exercise | $1.24 | 200 | 248 | 1,530 | Jun 22, 2021, 08:24 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 17, 2021 | Sale | $27.75 | 200 | 5,550 | 1,330 | Jun 22, 2021, 08:24 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 15, 2021 | Sale | $26.02 | 23,019 | 599,067 | 0 | Jun 16, 2021, 08:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Jun 14, 2021 | Sale | $25.92 | 14,003 | 362,921 | 23,019 | Jun 16, 2021, 08:21 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Mar 16, 2021 | Option Exercise | $0.94 | 4,600 | 4,302 | 4,600 | Mar 18, 2021, 09:39 PM |
LEVIN ARTHUR A | Chief Scientific Officer | Mar 16, 2021 | Sale | $27.87 | 4,600 | 128,181 | 0 | Mar 18, 2021, 09:39 PM |
Cormorant Asset Management, LP | Former 10% Owner | Jun 16, 2020 | Buy | $18.00 | 300,000 | 5,400,000 | 2,514,545 | Jun 18, 2020, 04:02 PM |
RTW INVESTMENTS, LP | 10% Owner | Jun 16, 2020 | Buy | $18.00 | 950,000 | 17,100,000 | 3,995,000 | Jun 16, 2020, 04:28 PM |
Owner | Relationship | Date | Value($) |
Boyce Sarah | President and CEO | 05/07/2024 | 34,720 |
Boyce Sarah | President and CEO | 05/07/2024 | 715,050 |
LEVIN ARTHUR A | Director | 04/19/2024 | 6,200 |
LEVIN ARTHUR A | Director | 04/19/2024 | 114,123 |
LEVIN ARTHUR A | Director | 04/03/2024 | 542,214 |
Boyce Sarah | President and CEO | 04/02/2024 | 34,720 |
Boyce Sarah | President and CEO | 04/02/2024 | 734,919 |
LEVIN ARTHUR A | Director | 03/19/2024 | 6,200 |
LEVIN ARTHUR A | Director | 03/19/2024 | 119,847 |
MacLean Michael F | Chief Financial Officer | 03/13/2024 | 352,800 |
MacLean Michael F | Chief Financial Officer | 03/13/2024 | 980,760 |
LEVIN ARTHUR A | Director | 03/12/2024 | 31,000 |
LEVIN ARTHUR A | Director | 03/12/2024 | 609,017 |
Boyce Sarah | President and CEO | 03/12/2024 | 34,720 |
Boyce Sarah | President and CEO | 03/08/2024 | 104,160 |
Boyce Sarah | President and CEO | 03/08/2024 | 1,796,710 |
Boyce Sarah | President and CEO | 03/12/2024 | 633,682 |
Boyce Sarah | President and CEO | 03/01/2024 | 104,160 |
Boyce Sarah | President and CEO | 03/01/2024 | 1,691,306 |
LEVIN ARTHUR A | Director | 01/22/2024 | 18,832 |
Boyce Sarah | President and CEO | 01/22/2024 | 51,582 |
Flanagan W. Michael | CSTO | 01/22/2024 | 41,827 |
McCarthy Teresa | Chief Human Resources Officer | 01/22/2024 | 20,918 |
MacLean Michael F | Chief Financial Officer | 01/22/2024 | 16,370 |
LEVIN ARTHUR A | Director | 03/15/2023 | 124 |
LEVIN ARTHUR A | Director | 03/15/2023 | 2,201 |
LEVIN ARTHUR A | Chief Scientific Officer | 02/14/2023 | 12,400 |
LEVIN ARTHUR A | Chief Scientific Officer | 02/14/2023 | 236,567 |
Boyce Sarah | President and CEO | 02/01/2023 | 1,116 |
Boyce Sarah | President and CEO | 02/03/2023 | 3,994 |
Boyce Sarah | President and CEO | 02/02/2023 | 56,890 |
Boyce Sarah | President and CEO | 02/03/2023 | 78,141 |
Boyce Sarah | President and CEO | 02/02/2023 | 1,117,741 |
Boyce Sarah | President and CEO | 02/01/2023 | 21,844 |
LEVIN ARTHUR A | Chief Scientific Officer | 01/12/2023 | 12,400 |
LEVIN ARTHUR A | Chief Scientific Officer | 01/12/2023 | 220,028 |
LEVIN ARTHUR A | Chief Scientific Officer | 12/29/2022 | 49,600 |
LEVIN ARTHUR A | Chief Scientific Officer | 12/29/2022 | 880,568 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/15/2022 | 57,802 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/12/2022 | 7,422 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/16/2022 | 4,339 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/15/2022 | 1,382,343 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/12/2022 | 308,066 |
LEVIN ARTHUR A | Chief Scientific Officer | 08/16/2022 | 77,257 |
Boyce Sarah | President and CEO | 08/24/2022 | 43,456 |
Boyce Sarah | President and CEO | 08/25/2022 | 18,420 |
Boyce Sarah | President and CEO | 08/24/2022 | 798,924 |
Boyce Sarah | President and CEO | 08/25/2022 | 342,690 |
Boyce Sarah | President and CEO | 08/15/2022 | 124 |
Boyce Sarah | President and CEO | 08/15/2022 | 2,247 |
LEVIN ARTHUR A | Chief Scientific Officer | 11/18/2021 | 30,571 |
LEVIN ARTHUR A | Chief Scientific Officer | 11/18/2021 | 697,218 |
RTW INVESTMENTS, LP | 10% Owner | 08/04/2021 | 14,400,000 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/25/2021 | 22,735 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/24/2021 | 124 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/25/2021 | 565,299 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/24/2021 | 2,775 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/17/2021 | 248 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/17/2021 | 5,550 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/15/2021 | 599,067 |
LEVIN ARTHUR A | Chief Scientific Officer | 06/14/2021 | 362,921 |
LEVIN ARTHUR A | Chief Scientific Officer | 03/16/2021 | 4,302 |
LEVIN ARTHUR A | Chief Scientific Officer | 03/16/2021 | 128,181 |
Cormorant Asset Management, LP | Former 10% Owner | 06/16/2020 | 5,400,000 |
RTW INVESTMENTS, LP | 10% Owner | 06/16/2020 | 17,100,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 6,165,991 | 0.00366% | -5.09% | Other |
RA CAPITAL MANAGEMENT, L.P. | 4,895,959 | 1.52% | 49.17% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,400,045 | 0.12% | 50% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,599,674 | 0.00378% | 3.39% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 51,055 | 0.00228% | -95.8% | Event Driven |
ORBIMED ADVISORS LLC | 994,100 | 0.46% | New | Other |
FARALLON CAPITAL MANAGEMENT LLC | 606,061 | 0.07% | New | Event Driven, Value |
CANDRIAM S.C.A. | 290,067 | 0.02% | Exited | Other |
RENAISSANCE TECHNOLOGIES LLC | 226,700 | 0.00318% | Exited | Other |
TUDOR INVESTMENT CORP ET AL | 68,887 | 0.01% | New | Event Driven, Other |
ALPS ADVISORS INC | 56,227 | 0.01% | 10.96% | Other |
D. E. SHAW & CO., INC. | 31,266 | 0.00068% | -24.63% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,708 | 0.00313% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View